Pricing Log in Create free account

Eledon Pharmaceuticals, Inc. (ELDN) vs PepGen, Inc. (PEPG)

Eledon Pharmaceuticals, Inc. and PepGen, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and PepGen, Inc. are of similar size ($184.5M and $175.2M). Across the 9 metrics below, Eledon Pharmaceuticals, Inc. leads on 5 and PepGen, Inc. on 4.

Valuation

Metric ELDN PEPG Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 7.33 1.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (42.72%) (50.38%) (33.15%)
Free cash flow yield (30.51%) (38.63%) (25.50%)

Profitability

Metric ELDN PEPG Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (236.51%) (75.45%) (56.36%)
Return on assets (72.74%) (59.06%) (48.04%)
Return on invested capital 0.00% (2,076.25%) 0.00%

Growth

Metric ELDN PEPG Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 30.67% 25.61% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELDN PEPG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.90 13.36 4.72
Net debt to EBITDA 1.60 1.64 0.96

Dividend

Metric ELDN PEPG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELDN PEPG Biotechnology median
Market cap 184.47m 175.22m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack